DC Investment Partners

Founded in 2019, Verana Networks specializes in developing innovative 5G Radio Access Network solutions for service providers who have licensed millimeter wave spectrum. Its focus is on enabling high-speed and high-capacity 5G services to drive new applications and revenue growth.

Kandou Bus specializes in designing high-speed, pin-efficient serial links for various applications. Its technology increases data transfer speed and reduces energy consumption, enabling improvements in devices like DRAM, graphics cards, servers, mobile devices, game consoles, routers, FPGAs, and defense electronics.

Werewolf Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative receptor agonists for cancer immunotherapy. Founded in 2017, the company is dedicated to creating therapeutics that stimulate the body’s immune system to combat cancer. Utilizing its proprietary PREDATOR platform, Werewolf designs conditionally activated molecules known as INDUKINE, which are engineered to remain inactive in peripheral tissues while selectively activating within the tumor microenvironment. This approach aims to overcome the limitations of traditional proinflammatory immune therapies, enhancing both adaptive and innate immunity to improve cancer treatment outcomes.

Founded in 2019, Verana Networks specializes in developing innovative 5G Radio Access Network solutions for service providers who have licensed millimeter wave spectrum. Its focus is on enabling high-speed and high-capacity 5G services to drive new applications and revenue growth.